Home Reports Exophthalmos Treatment Market

Exophthalmos Treatment Market

Exophthalmos Treatment Market is segmented by Treatment (Non-surgical Treatment, Surgical Treatment), End User (Specialty Clinics, Hospital Pharmacies, Others), Application (Hospital Pharmacies, Specialty Clinics, Ambulatory Surgical Centers, Other Applications), and Region. Forecast for 2026 to 2036.

Methodology

Exophthalmos Treatment Market Size, Market Forecast and Outlook By FMI

Summary of the Exophthalmos Treatment Market

  • Demand and Growth Drivers
    • Rising disease prevalence and improved diagnostic capabilities are likely to support demand for exophthalmos treatment solutions as healthcare systems focus on earlier intervention and evidence-based protocols.
    • Regulatory approvals for newer therapeutic agents are expected to expand the addressable patient population and create procurement opportunities across hospital and specialty clinic channels.
    • Increasing healthcare expenditure in Asia and Middle East regions is expected to support adoption of advanced treatment options during the forecast period.
  • Product and Segment View
    • Non-surgical Treatment is likely to remain a leading treatment segment with 57.6% share, supported by demand from hospital-based treatment protocols.
    • Specialty Clinics is likely to lead the end user segment with 57.8% share, reflecting institutional procurement patterns.
    • Emerging product categories and niche applications are expected to gain share incrementally as formulation technology and distribution access improve.
  • Geography and Competitive Outlook
    • Japan is likely to remain a key market owing to advanced healthcare infrastructure and high treatment adoption rates.
    • UK is likely to sustain demand on account of expanding healthcare access and regulatory modernization.
    • Companies that can combine clinical evidence with broad distribution access are likely to gain traction during the forecast period.
  • Analyst Opinion
    • The Exophthalmos Treatment market is evolving from a treatment-driven category into a structured therapeutic segment with clear commercial trajectories.
    • Adoption is being shaped by clinical outcomes data and reimbursement dynamics.
    • The market is also benefiting from increased attention to disease management protocols and preventive care strategies.
    • Demand is further supported by the need for solutions that balance clinical efficacy, patient compliance, and cost management across diverse healthcare settings.

Exophthalmos Treatment Market Value Analysis

Exophthalmos Treatment Market Definition

The exophthalmos treatment market encompasses pharmaceutical products, diagnostic tools, and therapeutic interventions that address the core requirements of treatment applications across end user, and related end-use categories. The market covers products segmented by treatment, end user, application, cause of condition, spanning the forecast period from 2026 to 2036.

Exophthalmos Treatment Market Inclusions

Market scope encompasses all commercially relevant exophthalmos treatment products categorized by Treatment, End User, Application, Cause Of Condition. The revenue scope covers the period from 2026 to 2036 across North America, Latin America, Europe, East Asia, South Asia and Pacific, and Middle East and Africa.

Exophthalmos Treatment Market Exclusions

The scope does not include over-the-counter supplements without regulatory approval, general wellness products not specific to the indicated condition, or devices and equipment used solely for diagnostic purposes without therapeutic function.

Exophthalmos Treatment Market Research Methodology

  • Primary Research: FMI analysts talked to clinical specialists, procurement officers at hospital networks, and pharmaceutical distributors in important markets.
  • Desk Research: This used information from regulatory filings, clinical trial registries, and manufacturer disclosures.
  • Market sizing and forecasting: Adding up from the bottom up across categories like treatment, end user, application, and cause of condition, with regional adoption curves.
  • Data validation: checked against global health databases and manufacturer filings every three months.

Why is the Exophthalmos Treatment Market Growing?

  • As the number of diseases rises and screening rates go up, there is a structured demand for evidence-based therapeutic products in hospitals and specialty clinics.
  • Japan is the fastest-growing country, with an 8.5% increase, thanks to its advanced healthcare system and wider access to treatment.
  • Regulatory modernization in many areas is speeding up the time it takes for new therapeutic options to reach the market, which is helping to increase sales.

The market for exophthalmos treatments is growing steadily, thanks to structural demand factors that are unlikely to change during the forecast period. Healthcare systems all over the world are putting more money into evidence-based treatment protocols, and payer systems are starting to cover a wider range of therapeutic options in this area.

57.6% of the treatment segment is made up of non-surgical treatments. This is in line with established clinical guidelines and the way doctors usually prescribe this treatment as a first-line option.

Changes in policies about treatment guidelines, responsible use of antibiotics, and payment systems are all factors that help the industry grow. As regulatory bodies in the EU, US, and Asia-Pacific revise clinical guidelines, the market for compliant therapeutic products grows.

Market Segmentation Analysis

  • The exophthalmos treatment market is segmented across 4 primary dimensions: Treatment, End User, Application, Cause Of Condition.
  • Non-surgical Treatment holds 57.6% of the treatment segment, reflecting its position as the primary therapeutic category.
  • Specialty Clinics leads the end user segment with 57.8% share, reflecting institutional procurement concentration.

The market for exophthalmos treatment is organized across product, end-use, and channel dimensions. Segmentation by treatment includes Non-surgical Treatment, Sympathomimetic Amines, Corticosteroids, Secondary Metabolites, Monoclonal Antibodies, Radiotherapy, Surgical Treatment, Orbital Decompression, Eye Muscle Surgery, Eyelid Surgery. By end user, the market includes Specialty Clinics, Hospital Pharmacies, Others.

Insights into the Non-surgical Treatment Treatment Segment

Exophthalmos Treatment Market Analysis By Treatment

In 2026, Non-surgical Treatment is expected to account for 57.6% of the treatment segment. This therapeutic category benefits from established clinical evidence, broad regulatory approval, and physician familiarity, making it the default choice in most treatment protocols.

Treatment protocols continue to evolve, and newer formulation approaches are expected to improve patient compliance and clinical outcomes within this segment. The expansion of treatment access in emerging markets is likely to sustain volume growth.

Insights into the Specialty Clinics End User Segment

Exophthalmos Treatment Market Analysis By End User

Specialty Clinics accounts for 57.8% of the end user segment. This channel benefits from concentrated purchasing authority, standardized procurement processes, and the clinical infrastructure needed to support treatment administration.

Exophthalmos Treatment Market Drivers, Restraints, and Opportunities

Exophthalmos Treatment Market Opportunity Matrix Growth Vs Value

  • Rising disease prevalence and evolving treatment guidelines are creating structured demand for therapeutic products that meet evidence-based clinical standards.
  • Higher development and manufacturing costs relative to generic alternatives limit adoption in price-sensitive healthcare systems, concentrating growth in reimbursed and premium segments.
  • Expansion of reimbursement coverage and guideline inclusion across emerging markets is expected to accelerate adoption during the forecast period.

The exophthalmos treatment market is shaped by a balance of demand-side growth factors and supply-side constraints. Clinical evidence continues to support market expansion, while cost management and access challenges moderate the pace of adoption in certain geographies.

Evolving Treatment Protocols and Clinical Guidelines

Demand reflects the ongoing evolution of clinical guidelines toward evidence-based treatment selection. As regulatory bodies update standard-of-care protocols, the addressable market for compliant products expands.

Cost and Access Constraints

Adoption is moderated by the cost differential between newer therapeutic options and established generic alternatives. Reimbursement dynamics and formulary inclusion decisions remain key determinants of market penetration.

Emerging Market Healthcare Expansion

Growth reflects increasing healthcare infrastructure investment across Asia, Latin America, and the Middle East. As hospital capacity and specialist access improve, treatment adoption rates in these regions are expected to converge toward developed market levels.

Analysis of Exophthalmos Treatment Market By Key Countries

Top Country Growth Comparison Exophthalmos Treatment Market Cagr (2026 2036)

Country CAGR
USA 8.1%
UK 8.2%
EU 8.0%
Japan 8.5%
South Korea 8.2%

Source: FMI analysis based on primary research and proprietary forecasting model

Exophthalmos Treatment Market Cagr Analysis By Country

  • Japan is in first place with a 8.5% CAGR, reflecting advanced healthcare infrastructure and high treatment penetration.
  • UK at 8.2% shows strong demand because of expanding treatment access and regulatory modernization.
  • South Korea (8.2%) and USA (8.1%) sustain growth through clinical adoption and healthcare system investments.
  • EU at 8.0% shows that healthcare modernization is expanding the treatment-addressable population.

The global exophthalmos treatment market is expected to grow at a rate of 8.1% per year from 2026 to 2036. The study covers more than 30 countries, and the main markets are listed below.

Demand Outlook for Exophthalmos Treatment Market in USA

Exophthalmos Treatment Market Country Value Analysis

The US will grow by 8.1% through 2036. This is supported by established healthcare infrastructure, clinical guideline adoption, and expanding treatment access.

  • Treatment protocol adoption supports procurement through hospital and specialty channels.
  • Reimbursement expansion and formulary updates accelerate patient access.
  • Clinical research investment supports development of next-generation treatment options.

Future Outlook for Exophthalmos Treatment Market in the United Kingdom

The UK will grow by 8.2% through 2036. This is supported by established healthcare infrastructure, clinical guideline adoption, and expanding treatment access.

  • Treatment protocol adoption supports procurement through hospital and specialty channels.
  • Reimbursement expansion and formulary updates accelerate patient access.
  • Clinical research investment supports development of next-generation treatment options.

Opportunity Analysis of Exophthalmos Treatment Market in the European Union

Exophthalmos Treatment Market Europe Country Market Share Analysis, 2026 & 2036

The European Union will grow by 8.0% through 2036. This is supported by established healthcare infrastructure, clinical guideline adoption, and expanding treatment access.

  • Treatment protocol adoption supports procurement through hospital and specialty channels.
  • Reimbursement expansion and formulary updates accelerate patient access.
  • Clinical research investment supports development of next-generation treatment options.

In-depth Analysis of Exophthalmos Treatment Market in Japan

Japan will grow by 8.5% through 2036. This is supported by established healthcare infrastructure, clinical guideline adoption, and expanding treatment access.

  • Treatment protocol adoption supports procurement through hospital and specialty channels.
  • Reimbursement expansion and formulary updates accelerate patient access.
  • Clinical research investment supports development of next-generation treatment options.

Sales Analysis of Exophthalmos Treatment Market in South Korea

South Korea will grow by 8.2% through 2036. This is supported by established healthcare infrastructure, clinical guideline adoption, and expanding treatment access.

  • Treatment protocol adoption supports procurement through hospital and specialty channels.
  • Reimbursement expansion and formulary updates accelerate patient access.
  • Clinical research investment supports development of next-generation treatment options.

Competitive Landscape and Strategic Positioning

Exophthalmos Treatment Market Analysis By Company

  • Horizon Therapeutics is the leader in the market with approximately 17.8% share, supported by broad product portfolio, global distribution, and clinical evidence base.
  • Novartis AG, Amgen Inc., and Viridian Therapeutics offer competitive product ranges that address diverse therapeutic needs and institutional procurement requirements.
  • New entrants are focusing on specialized applications and niche market segments where clinical differentiation and targeted therapeutic approaches create competitive advantage.

Horizon Therapeutics leads the market through a combination of clinical evidence, regulatory approvals, and distribution access across major healthcare systems. The competitive landscape is fragmented, with established players competing on clinical outcomes, pricing, and market access.

Barriers to entry include regulatory approval timelines, clinical trial investment requirements, and established physician prescribing relationships. Strategic priorities include expanding treatment access, strengthening clinical evidence, and improving cost competitiveness.

Key Companies in the Exophthalmos Treatment Market

Key global companies leading the exophthalmos treatment market include:

  • Horizon Therapeutics, Novartis AG, Amgen Inc., Viridian Therapeutics all have strong clinical portfolios, regulatory approvals, and distribution infrastructure across key markets.
  • Immunovant, Inc., Roche Holding AG, Regeneron Pharmaceuticals, Inc. have established regional strength through focused therapeutic expertise and local market knowledge.
  • Santen Pharmaceutical Co., Ltd., Apellis Pharmaceuticals, Inc., Kala Pharmaceuticals, Inc., Alcon Inc., Biogen Inc. are emerging players that have gained recognition through specialized therapeutic approaches and novel formulation technologies.

Competitive Benchmarking: Exophthalmos Treatment Market

Company Product Portfolio Clinical Evidence Distribution Reach Geographic Footprint
Horizon Therapeutics High Strong Strong Global
Novartis AG High Strong Strong Global
Amgen Inc. High Strong Strong Global
Viridian Therapeutics Medium Medium Moderate Regional
Immunovant, Inc. Medium Medium Moderate Regional
Roche Holding AG Medium Medium Moderate Regional
Regeneron Pharmaceuticals, Inc. Medium Medium Low Emerging
Santen Pharmaceutical Co., Ltd. Medium Medium Low Emerging
Apellis Pharmaceuticals, Inc. Medium Medium Low Emerging
Kala Pharmaceuticals, Inc. Medium Medium Low Emerging

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Exophthalmos Treatment Market

  • In 2025, Horizon Therapeutics (now part of Amgen Inc.) continued expanding the global adoption of TEPEZZA® for thyroid eye disease treatment by strengthening physician access programs and outpatient infusion support, improving treatment accessibility and patient compliance.
  • In 2025, Viridian Therapeutics, Inc. advanced late-stage clinical development of VRDN-001 and VRDN-003 for thyroid eye disease, supporting broader future treatment access rather than receiving direct regulatory approval for an expanded indication.

Key Players in the Exophthalmos Treatment Market

Major Global Players

  • Horizon Therapeutics
  • Novartis AG
  • Amgen Inc.
  • Viridian Therapeutics
  • Immunovant, Inc.
  • Roche Holding AG
  • Regeneron Pharmaceuticals, Inc.

Emerging Players/Startups

  • Santen Pharmaceutical Co., Ltd.
  • Apellis Pharmaceuticals, Inc.
  • Kala Pharmaceuticals, Inc.
  • Alcon Inc.
  • Biogen Inc.

Report Scope and Coverage

Quantitative Units USD 293.8 million to USD 640.2 million, at a CAGR of 8.1%
Market Definition The exophthalmos treatment market encompasses pharmaceutical products and therapeutic solutions across treatment, end user, application, cause of condition categories.
Regions Covered North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered USA, UK, EU, Japan, South Korea, 30 plus countries
Key Companies Profiled Horizon Therapeutics, Novartis AG, Amgen Inc., Viridian Therapeutics, Immunovant, Inc., Roche Holding AG, Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Apellis Pharmaceuticals, Inc., Kala Pharmaceuticals, Inc., Alcon Inc., Biogen Inc.
Forecast Period 2026 to 2036
Approach Hybrid bottom-up and top-down methodology starting with verified transaction data, projecting adoption velocity across segments and regions.

Segmentation

Exophthalmos Treatment Market Market Segmented by Treatment:

  • Non-surgical Treatment
    • Sympathomimetic Amines
    • Corticosteroids
    • Secondary Metabolites
    • Monoclonal Antibodies
    • Radiotherapy
  • Surgical Treatment
    • Orbital Decompression
    • Eye Muscle Surgery
    • Eyelid Surgery

Exophthalmos Treatment Market Market Segmented by End User:

  • Specialty Clinics
  • Hospital Pharmacies
  • Others

Exophthalmos Treatment Market Market Segmented by Application:

  • Hospital Pharmacies
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Other Applications

Exophthalmos Treatment Market Market Segmented by Cause Of Condition:

  • Graves’ Disease
  • Tumors
  • Inflammatory Disorders
  • Vascular Disorders

Exophthalmos Treatment Market Market by Region:

  • North America
    • USA
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Western Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Nordic
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Hungary
    • Balkan & Baltic
    • Rest of Eastern Europe
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia and Pacific
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of South Asia and Pacific
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkiye
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa

Research Sources and Bibliography

  • World Health Organization. (2025). Global Health Observatory Data Repository. WHO.
  • USA Food and Drug Administration. (2025). FDA Drug Approval Reports. FDA.
  • European Medicines Agency. (2025). EMA Annual Report on Medicinal Products. EMA.
  • International Pharmaceutical Federation. (2025). Global Pharmaceutical Market Report. FIP.
  • National Institutes of Health. (2025). NIH Research Portfolio Online Reporting Tools. NIH.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with publication dates, URLs, and supporting data for all cited works.

This Report Answers

  • Estimating the size of the market and revenue from 2026 to 2036.
  • Segmentation by treatment, end user, application, cause of condition.
  • Insights about more than 30 markets in the region.
  • Analysis of therapeutic approaches, clinical adoption, and regulatory dynamics.
  • Assessment of the competitive landscape.
  • Finding investment opportunities across therapeutic categories and geographic markets.
  • Keeping track of the supply chain.
  • Delivery of data in PDF and Excel formats.

Frequently Asked Questions

What is the global market demand for Exophthalmos Treatment in 2026?

In 2026, the global market for exophthalmos treatment is expected to be worth USD 293.8 million.

How big will the market for Exophthalmos Treatment be in 2036?

By 2036, the market for exophthalmos treatment is expected to be worth USD 640.2 million.

How much do you think demand for Exophthalmos Treatment will grow between 2026 and 2036?

Between 2026 and 2036, the demand for exophthalmos treatment is expected to grow at a CAGR of 8.1%.

Which Treatment segment is likely to be the best seller in the world by 2026?

Non-surgical Treatment is expected to account for 57.6% of the market in 2026, reflecting its established position in clinical treatment protocols.

What is causing demand to rise in Japan?

Japan will grow at a rate of 8.5% per year through 2036, supported by advanced healthcare infrastructure and expanding treatment access.

What is causing demand to rise in UK?

UK will grow at a rate of 8.2% per year through 2036, supported by expanding healthcare investment and regulatory modernization.

What does this report mean by "Exophthalmos Treatment Market definition"?

The exophthalmos treatment market includes pharmaceutical products and therapeutic solutions categorized by treatment, end user, application, cause of condition.

How does FMI make the Exophthalmos Treatment forecast and check it?

Forecasting models use a hybrid bottom-up and top-down approach, starting with verified transaction data and checking it against global health databases and manufacturer disclosures.

Table of Content

  1. Executive Summary
    • Global Market Outlook
    • Demand to side Trends
    • Supply to side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
  2. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  3. Research Methodology
    • Chapter Orientation
    • Analytical Lens and Working Hypotheses
      • Market Structure, Signals, and Trend Drivers
      • Benchmarking and Cross-market Comparability
      • Market Sizing, Forecasting, and Opportunity Mapping
    • Research Design and Evidence Framework
      • Desk Research Programme (Secondary Evidence)
        • Company Annual and Sustainability Reports
        • Peer-reviewed Journals and Academic Literature
        • Corporate Websites, Product Literature, and Technical Notes
        • Earnings Decks and Investor Briefings
        • Statutory Filings and Regulatory Disclosures
        • Technical White Papers and Standards Notes
        • Trade Journals, Industry Magazines, and Analyst Briefs
        • Conference Proceedings, Webinars, and Seminar Materials
        • Government Statistics Portals and Public Data Releases
        • Press Releases and Reputable Media Coverage
        • Specialist Newsletters and Curated Briefings
        • Sector Databases and Reference Repositories
        • FMI Internal Proprietary Databases and Historical Market Datasets
        • Subscription Datasets and Paid Sources
        • Social Channels, Communities, and Digital Listening Inputs
        • Additional Desk Sources
      • Expert Input and Fieldwork (Primary Evidence)
        • Primary Modes
          • Qualitative Interviews and Expert Elicitation
          • Quantitative Surveys and Structured Data Capture
          • Blended Approach
        • Why Primary Evidence is Used
        • Field Techniques
          • Interviews
          • Surveys
          • Focus Groups
          • Observational and In-context Research
          • Social and Community Interactions
        • Stakeholder Universe Engaged
          • C-suite Leaders
          • Board Members
          • Presidents and Vice Presidents
          • R&D and Innovation Heads
          • Technical Specialists
          • Domain Subject-matter Experts
          • Scientists
          • Physicians and Other Healthcare Professionals
        • Governance, Ethics, and Data Stewardship
          • Research Ethics
          • Data Integrity and Handling
      • Tooling, Models, and Reference Databases
    • Data Engineering and Model Build
      • Data Acquisition and Ingestion
      • Cleaning, Normalisation, and Verification
      • Synthesis, Triangulation, and Analysis
    • Quality Assurance and Audit Trail
  4. Market Background
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
      • Trends
    • Scenario Forecast
      • Demand in Optimistic Scenario
      • Demand in Likely Scenario
      • Demand in Conservative Scenario
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter’s Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  5. Global Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
    • Historical Market Size Value (USD Million) Analysis, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
      • Y to o to Y Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  6. Global Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
  7. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Treatment
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Treatment , 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Treatment , 2026 to 2036
      • Non-surgical Treatment
        • Sympathomimetic Amines
        • Corticosteroids
        • Secondary Metabolites
        • Monoclonal Antibodies
        • Radiotherapy
      • Surgical Treatment
        • Orbital Decompression
        • Eye Muscle Surgery
        • Eyelid Surgery
    • Y to o to Y Growth Trend Analysis By Treatment , 2021 to 2025
    • Absolute $ Opportunity Analysis By Treatment , 2026 to 2036
  8. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By End User
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By End User, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By End User, 2026 to 2036
      • Specialty Clinics
      • Hospital Pharmacies
      • Others
    • Y to o to Y Growth Trend Analysis By End User, 2021 to 2025
    • Absolute $ Opportunity Analysis By End User, 2026 to 2036
  9. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Application
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Application, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Application, 2026 to 2036
      • Hospital Pharmacies
      • Specialty Clinics
      • Ambulatory Surgical Centers
      • Other Applications
    • Y to o to Y Growth Trend Analysis By Application, 2021 to 2025
    • Absolute $ Opportunity Analysis By Application, 2026 to 2036
  10. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Cause Of Condition
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Cause Of Condition, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Cause Of Condition, 2026 to 2036
      • Graves’ Disease
      • Tumors
      • Inflammatory Disorders
      • Vascular Disorders
    • Y to o to Y Growth Trend Analysis By Cause Of Condition, 2021 to 2025
    • Absolute $ Opportunity Analysis By Cause Of Condition, 2026 to 2036
  11. Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
      • North America
      • Latin America
      • Western Europe
      • Eastern Europe
      • East Asia
      • South Asia and Pacific
      • Middle East & Africa
    • Market Attractiveness Analysis By Region
  12. North America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • USA
        • Canada
        • Mexico
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
    • Market Attractiveness Analysis
      • By Country
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
    • Key Takeaways
  13. Latin America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Brazil
        • Chile
        • Rest of Latin America
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
    • Market Attractiveness Analysis
      • By Country
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
    • Key Takeaways
  14. Western Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Germany
        • UK
        • Italy
        • Spain
        • France
        • Nordic
        • BENELUX
        • Rest of Western Europe
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
    • Market Attractiveness Analysis
      • By Country
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
    • Key Takeaways
  15. Eastern Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Russia
        • Poland
        • Hungary
        • Balkan & Baltic
        • Rest of Eastern Europe
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
    • Market Attractiveness Analysis
      • By Country
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
    • Key Takeaways
  16. East Asia Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • China
        • Japan
        • South Korea
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
    • Market Attractiveness Analysis
      • By Country
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
    • Key Takeaways
  17. South Asia and Pacific Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of South Asia and Pacific
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
    • Market Attractiveness Analysis
      • By Country
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
    • Key Takeaways
  18. Middle East & Africa Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Kingdom of Saudi Arabia
        • Other GCC Countries
        • Turkiye
        • South Africa
        • Other African Union
        • Rest of Middle East & Africa
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
    • Market Attractiveness Analysis
      • By Country
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
    • Key Takeaways
  19. Key Countries Market Analysis
    • USA
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • Canada
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • Mexico
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • Brazil
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • Chile
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • Germany
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • UK
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • Italy
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • Spain
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • France
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • India
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • ASEAN
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • Australia & New Zealand
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • China
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • Japan
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • South Korea
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • Russia
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • Poland
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • Hungary
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • Kingdom of Saudi Arabia
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • Turkiye
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
    • South Africa
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Treatment
        • By End User
        • By Application
        • By Cause Of Condition
  20. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Treatment
      • By End User
      • By Application
      • By Cause Of Condition
  21. Competition Analysis
    • Competition Deep Dive
      • Horizon Therapeutics
        • Overview
        • Product Portfolio
        • Profitability by Market Segments (Product/Age /Sales Channel/Region)
        • Sales Footprint
        • Strategy Overview
          • Marketing Strategy
          • Product Strategy
          • Channel Strategy
      • Novartis AG
      • Amgen Inc.
      • Viridian Therapeutics
      • Immunovant, Inc.
      • Roche Holding AG
      • Regeneron Pharmaceuticals, Inc.
      • Santen Pharmaceutical Co., Ltd.
      • Apellis Pharmaceuticals, Inc.
      • Kala Pharmaceuticals, Inc.
      • Alcon Inc.
      • Biogen Inc.
  22. Assumptions & Acronyms Used

List of Tables

  • Table 1: Global Market Value (USD Million) Forecast by Region, 2021 to 2036
  • Table 2: Global Market Value (USD Million) Forecast by Treatment , 2021 to 2036
  • Table 3: Global Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 4: Global Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 5: Global Market Value (USD Million) Forecast by Cause Of Condition, 2021 to 2036
  • Table 6: North America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 7: North America Market Value (USD Million) Forecast by Treatment , 2021 to 2036
  • Table 8: North America Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 9: North America Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 10: North America Market Value (USD Million) Forecast by Cause Of Condition, 2021 to 2036
  • Table 11: Latin America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 12: Latin America Market Value (USD Million) Forecast by Treatment , 2021 to 2036
  • Table 13: Latin America Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 14: Latin America Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 15: Latin America Market Value (USD Million) Forecast by Cause Of Condition, 2021 to 2036
  • Table 16: Western Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 17: Western Europe Market Value (USD Million) Forecast by Treatment , 2021 to 2036
  • Table 18: Western Europe Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 19: Western Europe Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 20: Western Europe Market Value (USD Million) Forecast by Cause Of Condition, 2021 to 2036
  • Table 21: Eastern Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 22: Eastern Europe Market Value (USD Million) Forecast by Treatment , 2021 to 2036
  • Table 23: Eastern Europe Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 24: Eastern Europe Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 25: Eastern Europe Market Value (USD Million) Forecast by Cause Of Condition, 2021 to 2036
  • Table 26: East Asia Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 27: East Asia Market Value (USD Million) Forecast by Treatment , 2021 to 2036
  • Table 28: East Asia Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 29: East Asia Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 30: East Asia Market Value (USD Million) Forecast by Cause Of Condition, 2021 to 2036
  • Table 31: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 32: South Asia and Pacific Market Value (USD Million) Forecast by Treatment , 2021 to 2036
  • Table 33: South Asia and Pacific Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 34: South Asia and Pacific Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 35: South Asia and Pacific Market Value (USD Million) Forecast by Cause Of Condition, 2021 to 2036
  • Table 36: Middle East & Africa Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 37: Middle East & Africa Market Value (USD Million) Forecast by Treatment , 2021 to 2036
  • Table 38: Middle East & Africa Market Value (USD Million) Forecast by End User, 2021 to 2036
  • Table 39: Middle East & Africa Market Value (USD Million) Forecast by Application, 2021 to 2036
  • Table 40: Middle East & Africa Market Value (USD Million) Forecast by Cause Of Condition, 2021 to 2036

List of Figures

  • Figure 1: Global Market Pricing Analysis
  • Figure 2: Global Market Value (USD Million) Forecast 2021-2036
  • Figure 3: Global Market Value Share and BPS Analysis by Treatment , 2026 and 2036
  • Figure 4: Global Market Y-o-Y Growth Comparison by Treatment , 2026-2036
  • Figure 5: Global Market Attractiveness Analysis by Treatment
  • Figure 6: Global Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 7: Global Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 8: Global Market Attractiveness Analysis by End User
  • Figure 9: Global Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 10: Global Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 11: Global Market Attractiveness Analysis by Application
  • Figure 12: Global Market Value Share and BPS Analysis by Cause Of Condition, 2026 and 2036
  • Figure 13: Global Market Y-o-Y Growth Comparison by Cause Of Condition, 2026-2036
  • Figure 14: Global Market Attractiveness Analysis by Cause Of Condition
  • Figure 15: Global Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
  • Figure 16: Global Market Y-o-Y Growth Comparison by Region, 2026-2036
  • Figure 17: Global Market Attractiveness Analysis by Region
  • Figure 18: North America Market Incremental Dollar Opportunity, 2026-2036
  • Figure 19: Latin America Market Incremental Dollar Opportunity, 2026-2036
  • Figure 20: Western Europe Market Incremental Dollar Opportunity, 2026-2036
  • Figure 21: Eastern Europe Market Incremental Dollar Opportunity, 2026-2036
  • Figure 22: East Asia Market Incremental Dollar Opportunity, 2026-2036
  • Figure 23: South Asia and Pacific Market Incremental Dollar Opportunity, 2026-2036
  • Figure 24: Middle East & Africa Market Incremental Dollar Opportunity, 2026-2036
  • Figure 25: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 26: North America Market Value Share and BPS Analysis by Treatment , 2026 and 2036
  • Figure 27: North America Market Y-o-Y Growth Comparison by Treatment , 2026-2036
  • Figure 28: North America Market Attractiveness Analysis by Treatment
  • Figure 29: North America Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 30: North America Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 31: North America Market Attractiveness Analysis by End User
  • Figure 32: North America Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 33: North America Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 34: North America Market Attractiveness Analysis by Application
  • Figure 35: North America Market Value Share and BPS Analysis by Cause Of Condition, 2026 and 2036
  • Figure 36: North America Market Y-o-Y Growth Comparison by Cause Of Condition, 2026-2036
  • Figure 37: North America Market Attractiveness Analysis by Cause Of Condition
  • Figure 38: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 39: Latin America Market Value Share and BPS Analysis by Treatment , 2026 and 2036
  • Figure 40: Latin America Market Y-o-Y Growth Comparison by Treatment , 2026-2036
  • Figure 41: Latin America Market Attractiveness Analysis by Treatment
  • Figure 42: Latin America Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 43: Latin America Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 44: Latin America Market Attractiveness Analysis by End User
  • Figure 45: Latin America Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 46: Latin America Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 47: Latin America Market Attractiveness Analysis by Application
  • Figure 48: Latin America Market Value Share and BPS Analysis by Cause Of Condition, 2026 and 2036
  • Figure 49: Latin America Market Y-o-Y Growth Comparison by Cause Of Condition, 2026-2036
  • Figure 50: Latin America Market Attractiveness Analysis by Cause Of Condition
  • Figure 51: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 52: Western Europe Market Value Share and BPS Analysis by Treatment , 2026 and 2036
  • Figure 53: Western Europe Market Y-o-Y Growth Comparison by Treatment , 2026-2036
  • Figure 54: Western Europe Market Attractiveness Analysis by Treatment
  • Figure 55: Western Europe Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 56: Western Europe Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 57: Western Europe Market Attractiveness Analysis by End User
  • Figure 58: Western Europe Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 59: Western Europe Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 60: Western Europe Market Attractiveness Analysis by Application
  • Figure 61: Western Europe Market Value Share and BPS Analysis by Cause Of Condition, 2026 and 2036
  • Figure 62: Western Europe Market Y-o-Y Growth Comparison by Cause Of Condition, 2026-2036
  • Figure 63: Western Europe Market Attractiveness Analysis by Cause Of Condition
  • Figure 64: Eastern Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 65: Eastern Europe Market Value Share and BPS Analysis by Treatment , 2026 and 2036
  • Figure 66: Eastern Europe Market Y-o-Y Growth Comparison by Treatment , 2026-2036
  • Figure 67: Eastern Europe Market Attractiveness Analysis by Treatment
  • Figure 68: Eastern Europe Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 69: Eastern Europe Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 70: Eastern Europe Market Attractiveness Analysis by End User
  • Figure 71: Eastern Europe Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 72: Eastern Europe Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 73: Eastern Europe Market Attractiveness Analysis by Application
  • Figure 74: Eastern Europe Market Value Share and BPS Analysis by Cause Of Condition, 2026 and 2036
  • Figure 75: Eastern Europe Market Y-o-Y Growth Comparison by Cause Of Condition, 2026-2036
  • Figure 76: Eastern Europe Market Attractiveness Analysis by Cause Of Condition
  • Figure 77: East Asia Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 78: East Asia Market Value Share and BPS Analysis by Treatment , 2026 and 2036
  • Figure 79: East Asia Market Y-o-Y Growth Comparison by Treatment , 2026-2036
  • Figure 80: East Asia Market Attractiveness Analysis by Treatment
  • Figure 81: East Asia Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 82: East Asia Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 83: East Asia Market Attractiveness Analysis by End User
  • Figure 84: East Asia Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 85: East Asia Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 86: East Asia Market Attractiveness Analysis by Application
  • Figure 87: East Asia Market Value Share and BPS Analysis by Cause Of Condition, 2026 and 2036
  • Figure 88: East Asia Market Y-o-Y Growth Comparison by Cause Of Condition, 2026-2036
  • Figure 89: East Asia Market Attractiveness Analysis by Cause Of Condition
  • Figure 90: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 91: South Asia and Pacific Market Value Share and BPS Analysis by Treatment , 2026 and 2036
  • Figure 92: South Asia and Pacific Market Y-o-Y Growth Comparison by Treatment , 2026-2036
  • Figure 93: South Asia and Pacific Market Attractiveness Analysis by Treatment
  • Figure 94: South Asia and Pacific Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 95: South Asia and Pacific Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 96: South Asia and Pacific Market Attractiveness Analysis by End User
  • Figure 97: South Asia and Pacific Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 98: South Asia and Pacific Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 99: South Asia and Pacific Market Attractiveness Analysis by Application
  • Figure 100: South Asia and Pacific Market Value Share and BPS Analysis by Cause Of Condition, 2026 and 2036
  • Figure 101: South Asia and Pacific Market Y-o-Y Growth Comparison by Cause Of Condition, 2026-2036
  • Figure 102: South Asia and Pacific Market Attractiveness Analysis by Cause Of Condition
  • Figure 103: Middle East & Africa Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 104: Middle East & Africa Market Value Share and BPS Analysis by Treatment , 2026 and 2036
  • Figure 105: Middle East & Africa Market Y-o-Y Growth Comparison by Treatment , 2026-2036
  • Figure 106: Middle East & Africa Market Attractiveness Analysis by Treatment
  • Figure 107: Middle East & Africa Market Value Share and BPS Analysis by End User, 2026 and 2036
  • Figure 108: Middle East & Africa Market Y-o-Y Growth Comparison by End User, 2026-2036
  • Figure 109: Middle East & Africa Market Attractiveness Analysis by End User
  • Figure 110: Middle East & Africa Market Value Share and BPS Analysis by Application, 2026 and 2036
  • Figure 111: Middle East & Africa Market Y-o-Y Growth Comparison by Application, 2026-2036
  • Figure 112: Middle East & Africa Market Attractiveness Analysis by Application
  • Figure 113: Middle East & Africa Market Value Share and BPS Analysis by Cause Of Condition, 2026 and 2036
  • Figure 114: Middle East & Africa Market Y-o-Y Growth Comparison by Cause Of Condition, 2026-2036
  • Figure 115: Middle East & Africa Market Attractiveness Analysis by Cause Of Condition
  • Figure 116: Global Market - Tier Structure Analysis
  • Figure 117: Global Market - Company Share Analysis

Full Research Suite comprises of:

Market outlook & trends analysis

Market outlook & trends analysis

Interviews & case studies

Interviews & case studies

Strategic recommendations

Strategic recommendations

Vendor profiles & capabilities analysis

Vendor profiles & capabilities analysis

5-year forecasts

5-year forecasts

8 regions and 60+ country-level data splits

8 regions and 60+ country-level data splits

Market segment data splits

Market segment data splits

12 months of continuous data updates

12 months of continuous data updates

DELIVERED AS:

PDF EXCEL ONLINE

Free Sample Report Download PDF

Full Research Suite

$5000

$7500

$10000

Buy Report Now